Evidence map›Paper›PMID 41990919›Full record

ArticleTransplantation and cellular therapy2026

It Mite Not Be Graft-Versus-Host Disease: Frequency and Clinical Features of Demodex Folliculitis After Allogeneic Hematopoietic Cell Transplantation.

Elisabetta Xue, Alison Cusmano, Mustafa A Hyder, Dimana Dimitrova, Ruby Sabina, Kamil Rechache, Jill Allbritton, Erich Huang, Isaac Brownell, Leslie Castelo-Soccio and 8 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Transplantation and cellular therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Elisabetta XueCenter for Immuno-Oncology, National Cancer Institute, National Institutes of Health, Bethesda Maryland.
Alison CusmanoCenter for Immuno-Oncology, National Cancer Institute, National Institutes of Health, Bethesda Maryland.
Mustafa A HyderCenter for Immuno-Oncology, National Cancer Institute, National Institutes of Health, Bethesda Maryland.
Dimana DimitrovaCenter for Immuno-Oncology, National Cancer Institute, National Institutes of Health, Bethesda Maryland.
Ruby SabinaCenter for Immuno-Oncology, National Cancer Institute, National Institutes of Health, Bethesda Maryland.
Kamil RechacheCenter for Immuno-Oncology, National Cancer Institute, National Institutes of Health, Bethesda Maryland.
Jill AllbrittonDermatopathology Section, The Joint Pathology Center, Silver Spring, Maryland.
Erich HuangBiometric Research Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Isaac BrownellDermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland.
Leslie Castelo-SoccioDermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland.
Keisuke NagaoDermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland.
Heidi H KongDermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland.
Kelli KarackiDermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland.
Chantal Cousineau-KriegerConsult Services Section, National Eye Institute, National Institutes of Health, Bethesda, Maryland.
Maria Teresa MagoneConsult Services Section, National Eye Institute, National Institutes of Health, Bethesda, Maryland.
Edward W CowenDermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland.
Jennifer A KanakryCenter for Immuno-Oncology, National Cancer Institute, National Institutes of Health, Bethesda Maryland.
Christopher G KanakryCenter for Immuno-Oncology, National Cancer Institute, National Institutes of Health, Bethesda Maryland. Electronic address: christopher.kanakry@nih.gov.

Funding

Deciphering the efficacy of posttransplant cyclophosphamide in haplo transplantZIABC011659 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KANAKRY, CHRISTOPHER · 2015 to 2025
$18.5M
Intramural NIH HHS Z99 CA999999Intramural NIH HHS ZIA BC011659
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41990919
PMCPMC13128285

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.